Immuneel Therapeutics Pvt. Ltd.

German multinational Miltenyi Biotec’s senior leadership sees significant opportunities for India in the cell and gene therapy space if it can get things right in terms of shaping the regulatory frame

The new year promises to be one of multifaceted action in India ranging from deal appetite and growing big pharma interest in global capability centers (GCCs), besides some big-ticket launches, to re

Advanced therapies, including cell and gene therapy, have demonstrated the potential to revolutionize the treatment of previously incurable diseases. Since the first CAR-T was introduced in 2017, the